Epizyme, Inc.
Combination therapy for treating cancer

Last updated:

Abstract:

The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.

Status:
Grant
Type:

Utility

Filling date:

5 Aug 2020

Issue date:

28 Jun 2022